severe cutaneous adverse reaction
severe cutaneous adverse reaction
Explore linked clinical trials. Standard reference: MONDO:0005594106 results · Page 1 of 5
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Disposable Noninvasive Skin Closure for Promoting Postoperative Wound Healing and Preventing Surgical Skin Scarring | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, severe cutaneous adverse reaction | Recruiting | Not applicable | 2026-10-09 | NCT07849010 | |
| SCARFREE-001: Verteporfin for Scar Prevention | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, severe cutaneous adverse reaction | Not yet recruiting | Phase 2 | 2026-10-05 | NCT07488988 | |
| Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen' | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, severe cutaneous adverse reaction, skin disorder | Recruiting | Not applicable | 2026-10-02 | NCT06336044 | |
| Hypertrophic Scar Prosthetic Pressure in Burn Amputee | Cicatrix, Hypertrophic, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Ulcer, Skin and Connective Tissue Diseases, burn, decubitus ulcer, injury, severe cutaneous adverse reaction, skin disorder | Not yet recruiting | Not stated | 2026-09-30 | NCT07850557 | |
| Post-Operative Use of FS2 to Mitigate Scarring in Burn Patients | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, burn, injury, severe cutaneous adverse reaction | Recruiting | Phase 2 / Phase 3 | 2026-09-30 | NCT06807021 | |
| Impact of Early Physiotherapy on Pain, Quality of Life, Pelvic Floor Function, and Sexual Health Post-Episiotomy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibrosis, Genital Diseases, Male Urogenital Diseases, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sexual Dysfunctions, Psychological, Signs and Symptoms, Urogenital Diseases, female reproductive system disorder, male reproductive system disorder, physiological sexual disorder, psychiatric disorder, psychologic dyspareunia, severe cutaneous adverse reaction | Recruiting | Not applicable | 2026-09-30 | NCT06568406 | |
| 3D MRE-Based Evaluation of Vestibular Schwannoma Mechanical Properties and Histological Features | Ear Diseases, Fibrosis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Otorhinolaryngologic Neoplasms, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tissue Adhesions, acoustic neuroma, cranial nerve neoplasm, cranial nerve neuropathy, neoplasm, nerve sheath neoplasm, nervous system disorder, neuroendocrine neoplasm, neuroma, otorhinolaryngologic disease, peripheral nervous system neoplasm, primitive neuroectodermal tumor, retrocochlear disease, schwannoma, severe cutaneous adverse reaction, vestibulocochlear nerve disorder | Enrolling by invitation | Not stated | 2026-09-28 | NCT07844460 | |
| Poly-4-Hydroxybutyrate Scaffold in Rhytidectomy | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tissue Adhesions, severe cutaneous adverse reaction | Active, not recruiting | Not applicable | 2026-09-25 | NCT07132892 | |
| Transdermal Versus Intralesional Betamethasone for Keloids | Collagen Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, keloid, severe cutaneous adverse reaction | Active, not recruiting | Not applicable | 2026-09-23 | NCT07835438 | |
| Effect of an Intraoperative Polynucleotide Injection on Scar Quality After Thyroidectomy | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, severe cutaneous adverse reaction | Not yet recruiting | Not applicable | 2026-09-23 | NCT07791953 | |
| AVAVA MIRIA General Use | Acneiform Eruptions, Fibrosis, Hypertrophy, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, severe cutaneous adverse reaction, skin disorder | Recruiting | Not applicable | 2026-09-15 | NCT06868615 | |
| Lipofilling in Operative Hand Fracture Treatment | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tissue Adhesions, bone fracture, injury, severe cutaneous adverse reaction | Not yet recruiting | Not applicable | 2026-09-11 | NCT07815444 | |
| Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds | Cicatrix, Hypertrophic, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, severe cutaneous adverse reaction | Recruiting | Not applicable | 2026-09-03 | NCT05984628 | |
| Zinc Oxide Versus Petrolatum Following Skin Surgery | Cicatrix, Hypertrophic, Fibrosis, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Surgical Wound, Surgical Wound Infection, Wound Infection, injury, severe cutaneous adverse reaction | Recruiting | Early phase 1 | 2026-09-02 | NCT03561376 | |
| Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy | Collagen Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, keloid, severe cutaneous adverse reaction | Recruiting | Phase 2 | 2026-09-01 | NCT06373458 | |
| Radiotherapy for Keloids | Collagen Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, keloid, severe cutaneous adverse reaction | Recruiting | Not applicable | 2026-08-28 | NCT04722263 | |
| Carbon Dioxide Laser-Assisted Delivery of Triamcinolone With or Without 5-Fluorouracil for Hypertrophic Burn Scars | Cicatrix, Hypertrophic, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, burn, injury, severe cutaneous adverse reaction | Not yet recruiting | Not applicable | 2026-08-24 | NCT07660120 | |
| Dermabrasion for Free Flap Aesthetic Enhancement | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, severe cutaneous adverse reaction | Not yet recruiting | Not applicable | 2026-08-24 | NCT07233200 | |
| Influence of Sun Protection and Linear Repair of Cutaneous Surgical Defects | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Surgical Wound, injury, severe cutaneous adverse reaction | Active, not recruiting | Not applicable | 2026-08-18 | NCT05074238 | |
| RFA for Superficial Lipomas | Fibrosis, Neoplasms by Histologic Type, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, lipoma, neoplasm, severe cutaneous adverse reaction | Recruiting | Not applicable | 2026-08-14 | NCT06903208 | |
| Phase III Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, burn, injury, severe cutaneous adverse reaction | Recruiting | Phase 3 | 2026-08-10 | NCT06745557 | |
| Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, burn, injury, severe cutaneous adverse reaction | Active, not recruiting | Phase 2 | 2026-08-06 | NCT03229564 | |
| The Study Examines the Efficacy of Treating Limb Scars Using a Combined Pressure Garment and Silicone Sheet Compared to Treatment With a Pressure Garment Alone. The Study Aims to Develop a Comprehensive Scar Assessment Framework, Integrating Objective and Subjective Tools to Evaluate Treatment | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, severe cutaneous adverse reaction | Not yet recruiting | Not applicable | 2026-08-04 | NCT07744867 | |
| Scar Gel Product Family Clinical Investigation | Cicatrix, Hypertrophic, Collagen Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, keloid, severe cutaneous adverse reaction | Not yet recruiting | Not stated | 2026-07-06 | NCT07684573 | |
| Keloid Pathogenesis And Fibroblast Activation Study | Collagen Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, keloid, severe cutaneous adverse reaction | Recruiting | Not stated | 2026-07-06 | NCT07682636 |